Vivos Therapeutics, Inc. Warrant, Down Round Feature, (Increase) Decrease in Equity, Amount
Vivos Therapeutics, Inc. (VVOS) reported Warrant, Down Round Feature, (Increase) Decrease in Equity, Amount of -$3.60 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-31.
Discontinued › Notes
us-gaap:WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount · last filed 2022-03-31
- Vivos Therapeutics, Inc. warrant, down round feature, (increase) decrease in equity, amount for fiscal 2020 was -$3.60M.
| Period end | Warrant, Down Round Feature, (Increase) Decrease in Equity, Amount 12 month | Warrant, Down Round Feature, (Increase) Decrease in Equity, Amount 12 month as first filed |
|---|---|---|
| 2020-12-31 | -$3.60M 10-K · filed 2022-03-31 | $3.60M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |